Sept. 6th Deadline ALERT: Investors Who Lost More Than $100,000 With SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW) Shares Should Contact the Shareholders Foundation

mail@shareholdersfoundation.com

The Shareholders Foundation, Inc. announced that a deadline is coming up on October 31, 2024 in the lawsuit that was filed for certain investors who purchased shares of SeaStar Medical Holding Corporation (NASDAQ:ICU)(NASDAQ:ICUCW). Investors in SeaStar Medical Holding Corporation (NASDAQ:ICU)(NASDAQ:ICUCW) shares should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554

The Shareholders Foundation, Inc. announced that a deadline is coming up on October 31, 2024 in the lawsuit that was filed for certain investors who purchased shares of SeaStar Medical Holding Corporation (NASDAQ:ICU)(NASDAQ:ICUCW).

Investors, who purchased shares in excess of $100,000 of SeaStar Medical Holding Corporation (NASDAQ:ICU)(NASDAQ:ICUCW) between October 31, 2022 and March 26, 2024, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On July 02, 2024, an investor in SeaStar Medical Holding Corporation (NASDAQ:ICU)(NASDAQ:ICUCW) shares filed a lawsuit against SeaStar Medical Holding Corporation. The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that SeaStar and/or Legacy SeaStar had deficient compliance controls and procedures related to the HDE Application, that accordingly, there were deficiencies with the HDE Application, the FDA was unlikely to approve the HDE Application in its present form, and the SCD's regulatory prospects were overstated, that the Company had downplayed the true scope and severity of deficiencies in its financial controls and procedures, while overstating defendants' efforts to remediate the same, that accordingly, SeaStar had failed to properly account for the classification of certain outstanding warrants and the Prepaid Forward Agreement, that as a result, SeaStar was likely to restate one or more of its previously issued financial statements, that accordingly, SeaStar's post-Merger business and financial prospects were overstated.

Those who purchased SeaStar Medical Holding Corporation (NASDAQ:ICU)(NASDAQ:ICUCW) shares should contact the Shareholders Foundation, Inc.

CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

Contact Information
Michael Daniels
Manager
mail@shareholdersfoundation.com
858-779-1554

SOURCE: Shareholders Foundation, Inc.

Source: Shareholders Foundation, Inc.

Related Media

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

Shareholders Foundation, Inc.
3111 Camino del Rio N Ste 423
San Diego, CA
92108-5720

Contacts


More Press Releases